TXNIP Regulates Peripheral Glucose Metabolism in Humans
Open accessThe DOI matches its Crossref record; 58 of the 58 references it cites were found in a registry or an index.
Abstract
BACKGROUND: Type 2 diabetes mellitus (T2DM) is characterized by defects in insulin secretion and action. Impaired glucose uptake in skeletal muscle is believed to be one of the earliest features in the natural history of T2DM, although underlying mechanisms remain obscure. METHODS AND FINDINGS: We combined human insulin/glucose clamp physiological studies with genome-wide expression profiling to identify thioredoxin interacting protein (TXNIP) as a gene whose expression is powerfully suppressed by insulin yet stimulated by glucose. In healthy individuals, its expression was inversely correlated to total body measures of glucose uptake. Forced expression of TXNIP in cultured adipocytes significantly reduced glucose uptake, while silencing with RNA interference in adipocytes and in skeletal muscle enhanced glucose uptake, confirming that the gene product is also a regulator of glucose uptake. TXNIP expression is consistently elevated in the muscle of prediabetics and diabetics, although in a panel of 4,450 Scandinavian individuals, we found no evidence for association between common genetic variation in the TXNIP gene and T2DM. CONCLUSIONS: TXNIP regulates both insulin-dependent and insulin-independent pathways of glucose uptake in human skeletal muscle. Combined with recent studies that have implicated TXNIP in pancreatic beta-cell glucose toxicity, our data suggest that TXNIP might play a key role in defective glucose homeostasis preceding overt T2DM.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Figures

![Figure 2 TXNIP Expression in Individuals with Diabetes or at Risk for Developing Diabetes (A) TXNIP expression levels from individuals with NGT, IGT, or T2DM, using data from our previously published microarray study [18]. * p < 0.02; ** p < 0.01, Mann-Whitney U-test. (B) TXNIP expression levels from NGT individuals with family history of T2DM (FH+) or without (FH−), as well as individuals with T2DM, using data from a previously published microarray study [27]. * p < 0.03, Mann-Whitney U-test.](https://figures.cochat.ai/paper-figures/ca9ef16bc19d42259bbcc36f2b7c4340/txnip-regulates-peripheral-glucose-metabolism-in-humans-figure-2.jpg)

![Figure 4 Insulin-Mediated Glucose Uptake Versus TXNIP Expression This relationship is shown for individuals with NGT, IGT, and T2DM. Linear regression parameters are indicated for each of the groups. Data are from our previously published microarray study [18].](https://figures.cochat.ai/paper-figures/c969253506d74789b5b972b212cc68b2/txnip-regulates-peripheral-glucose-metabolism-in-humans-figure-4.jpg)

![Figure 6 Pattern of Genetic Variation at the TXNIP Locus Linkage disequilibrium between SNPs was analyzed using Haploview [55], and D′ values were calculated with 95% confidence intervals. D′ plot for each square depicts the magnitude of linkage disequilibrium for a pair of markers, red indicates high D′ with high logarithm of odds (LOD) score, while white indicates low D′ with low LOD score, and blue indicates high D′ with low LOD score.](https://figures.cochat.ai/paper-figures/1e45333953bb4d3999d14146d7c357ce/txnip-regulates-peripheral-glucose-metabolism-in-humans-figure-6.jpg)
![Figure 7 Model of TXNIP Regulation and Action and Its Potential Role in the Pathogenesis of T2DM (A) Previous studies have shown that glucose induces the expression of TXNIP in a variety of cells and tissues. In this study we show that insulin suppresses the expression of TXNIP. Moreover, we have found that forced expression of TXNIP results in reduced glucose uptake, while inhibition of TXNIP enhances glucose uptake. These results suggest that TXNIP serves as a glucose- and insulin-sensitive homeostatic switch that regulates glucose uptake in the periphery. (B) Role of TXNIP in glucose toxicity in the β-cell and in impaired glucose uptake in the periphery. Insulin deficiency or hyperglycemia can increase TXNIP levels in muscle, resulting in impaired peripheral glucose uptake. The pancreatic β-cell is initially able to compensate by secreting more insulin, but eventually the β-cell compensation fails. The resulting hyperglycemia may then elevate pancreatic β-cell TXNIP expression, which can induce apoptosis [40]. The loss of β-cells, in turn, results in decreased insulin production that further exacerbates peripheral IGT. The vicious cycle would eventually spiral to T2DM.](https://figures.cochat.ai/paper-figures/00021f5e308f4c0db15afac10c663543/txnip-regulates-peripheral-glucose-metabolism-in-humans-figure-7.jpg)
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The cited source says what the claim attributes to it.
In the citing paper
“TXNIP not only binds to and inhibits thioredoxin, but also antagonizes glucose uptake through a yet undefined mechanism (Parikh et al., 2007).”
From Lipid-Induced Mitochondrial Stress and Insulin Action in Muscle (2012) · cites this paper as Parikh et al., 2007
In the citing paper
“TXNIP not only binds to and inhibits thioredoxin, but also antagonizes glucose uptake through a yet undefined mechanism (Parikh et al., 2007).”
From Lipid-Induced Mitochondrial Stress and Insulin Action in Muscle (2012) · cites this paper as Parikh et al., 2007
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Single-step method of RNA isolation by acid guanidinium thiocyanate-phenol-chloroform extraction
Chomczynski, P., & Sacchi, N. (1987) · Analytical Biochemistry · doi:10.1016/0003-2697(87)90021-2 · Cited by 46,426 · cited 1×
“RNA Isolation, Target Preparation, and Hybridization RNA from skeletal muscle biopsies for studies A and B were extracted by the guadinium thiocyanate method [11].”
MethodHaploview: analysis and visualization of LD and haplotype maps
Barrett, J. C., Fry, B., Maller, J., & Daly, M. J. (2005) · Bioinformatics · doi:10.1093/bioinformatics/bth457 · Cited by 14,525 · cited 1×
“Linkage disequilibrium between SNPs was analyzed using Haploview [55], and D9 values were calculated with 95% confidence intervals.”
MethodGolub, T. R., Slonim, D. K., Tamayo, P., Huard, C., Gaasenbeek, M., Mesirov, J. P., Coller, H., Loh, M. L., Downing, J. R., Caligiuri, M. A., et al. (1999) · Science · doi:10.1126/science.286.5439.531 · Cited by 11,516 · cited 1×
“For study A, targets from human skeletal muscle biopsies [12] were hybridized to the Affymetrix HG-U133A GeneChip (http://www.”
MethodIn silico prediction of protein-protein interactions in human macrophages
Souiai, O., Guerfali, F., Ben Miled, S., Brun, C., & Benkahla, A. (2014) · BMC Research Notes · doi:10.1186/1756-0500-7-157 · Cited by 10,803
Significance analysis of microarrays applied to the ionizing radiation response
Tusher, V. G., Tibshirani, R., & Chu, G. (2001) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.091062498 · Cited by 10,568
Mootha, V. K., Lindgren, C. M., Eriksson, K.-F., Subramanian, A., Sihag, S., Lehar, J., Puigserver, P., Carlsson, E., Ridderstråle, M., Laurila, E., et al. (2003) · Nature Genetics · doi:10.1038/ng1180 · Cited by 10,197
Self-citationBiochemistry and molecular cell biology of diabetic complications
Brownlee, M. (2001) · Nature · doi:10.1038/414813a · Cited by 9,107
Longitudinal Data Analysis for Discrete and Continuous Outcomes
Zeger, S. L., & Liang, K.-Y. (1986) · Biometrics · doi:10.2307/2531248 · Cited by 7,764 · cited 1×
“To relate expression data with insulin-stimulated glucose uptake, a GEE model was used to adjust for the interdependence between twins [9,30].”
MethodBase-Calling of Automated Sequencer Traces Using Phred. I. Accuracy Assessment
Ewing, B., Hillier, L., Wendl, M. C., & Green, P. (1998) · Genome Research · doi:10.1101/gr.8.3.175 · Cited by 6,967 · cited 1×
“Each base was called using the PHRED software package [19,20], and quality scores were assigned.”
MethodBase-Calling of Automated Sequencer Traces Using Phred. II. Error Probabilities
Ewing, B., & Green, P. (1998) · Genome Research · doi:10.1101/gr.8.3.186 · Cited by 5,439 · cited 1×
“]. Genomic DNA was isolated from peripheral blood using standard procedures. We used specific primers (Applied Biosystems) to amplify the region by PCR. Sequencing was performed using Big Dye version 3.1 Cycle Sequencing kit (Applied Biosystems) according to the manufacturer's instructions, and separation was done on…”
MethodInfluential
Research works printed but not linked: 56
- Kahn, 1994, Diabetes, 43, 1066
- Eriksson, 1989, N Engl J Med, 321, 337
- Lyssenko, 2005, Diabetes, 54, 166
- Martin, 1992, Lancet, 340, 925
- Groop, 1996, Diabetes, 45, 1585
- Roden, 2005, Int J Obes, 2, S111
- Shulman, 2000, J Clin Invest, 106, 171
- Eriksson, 1990, Diabetologia, 33, 526
- Ling, 2004, J Clin Invest, 114, 1518
- Poulsen, 2005, Diabetes, 54, 275
- Chomczynski, 1987, Anal Biochem, 162, 156
- Golub, 1999, Science, 286, 531
- Wabitsch, 2001, Int J Obes Relat Metab Disord, 25, 8
- Al-Khalili, 2003, Cell Mol Life Sci, 60, 991
- Rubin, 1977, J Biol Chem, 252, 3554
- Al-Khalili, 2003, Biochem Biophys Res Commun, 307, 127
- Yoshioka, 2004, Circulation, 109, 2581
- Mootha, 2003, Nat Genet, 34, 267
- Ewing, 1998, Genome Res, 8, 186
- Ewing, 1998, Genome Res, 8, 175
- Staden, 1996, Mol Biotechnol, 5, 233
- de Bakker, 2005, Nat Genet, 37, 1217
- Florez, 2004, Diabetes, 53, 3313
- Purcell, 2003, Bioinformatics, 19, 149
- McClintick, 2006, BMC Bioinformatics, 7, 49
- Tusher, 2001, Proc Natl Acad Sci U S A, 98, 5116
- Patti, 2003, Proc Natl Acad Sci U S A, 100, 8466
- Yechoor, 2002, Proc Natl Acad Sci U S A, 99, 10587
- Yechoor, 2004, Proc Natl Acad Sci U S A, 101, 16525
- Zeger, 1986, Biometrics, 42, 121
- Zandbergen, 2005, Biochem J, 392, 313
- Phan, 2004, Nature, 432, 635
- Lee, 2003, Science, 302, 453
- Nishiyama, 1999, J Biol Chem, 274, 21645
- Shalev, 2002, Endocrinology, 143, 3695
- Hirota, 2002, J Biol Chem, 277, 44244
- Kobayashi, 2003, Kidney Int, 64, 1632
- Schulze, 2004, J Biol Chem, 279, 30369
- Hansen, 2004, Biochem Biophys Res Commun, 323, 685
- Minn, 2005, Endocrinology, 146, 2397
- Wolfrum, 2003, Proc Natl Acad Sci U S A, 100, 11624
- Elbein, 1999, Diabetes, 48, 1175
- Vionnet, 2000, Am J Hum Genet, 67, 1470
- Donnelly, 2004, J Nutr, 134, 1475
- Sheth, 2005, J Lipid Res, 46, 123
- Brownlee, 2001, Nature, 414, 813
- Houstis, 2006, Nature, 440, 944
- Petersen, 2003, Science, 300, 1140
- Wang, 2006, Oncogene, 25, 1903
- Han, 2003, Oncogene, 22, 4035
- DeFronzo, 2004, Med Clin North Am, 88
- Bonner-Weir, 2000, Trends Endocrinol Metab, 11, 375
- Poitout, 2002, Endocrinology, 143, 339
- Zierath, 2003, Best Pract Res Clin Endocrinol Metab, 17, 385
- Barrett, 2005, Bioinformatics, 21, 263
- Furuyama, 2000, Biochem J, 349, 629
Cited by
Items 101–200 of 499
Thioredoxin interacting protein (TXNIP) is a novel tumor suppressor in thyroid cancer
Morrison, J. A., Pike, L. A., Sams, S. B., Sharma, V., Zhou, Q., Severson, J. J., Tan, A. C., Wood, W. M., & Haugen, B. R. (2014) · Molecular Cancer · doi:10.1186/1476-4598-13-62 · Cited by 110
“TXNIP is also a known inhibitor of glucose uptake [5,7,11].”
BackgroundHormonal and Metabolite Regulation of Hepatic Glucokinase
Agius, L. (2016) · Annual Review of Nutrition · doi:10.1146/annurev-nutr-071715-051145 · Cited by 101
Park, M.-J., Kim, D., Lim, S.-K., Choi, J., Kim, J.-C., Yoon, K. C., Lee, J.-B., Lee, J.-H., Han, H. J., Choi, I., et al. (2014) · Journal of Hepatology · doi:10.1016/j.jhep.2014.06.032 · Cited by 105
“TXNIP expression is strongly upregulated in human diabetes [8] and diabetic complications [25], indicating that TXNIP is a potential diabetogenic signal.”
BackgroundGlucose sensing by ChREBP/MondoA–Mlx transcription factors
Havula, E., & Hietakangas, V. (2012) · Seminars in Cell and Developmental Biology · doi:10.1016/j.semcdb.2012.02.007 · Cited by 117
Epigenetic regulation of the thioredoxin-interacting protein (TXNIP) gene by hyperglycemia in kidney
Marinis, Y. Z. D., Cai, M., Bompada, P., Atac, D., Kotova, O., Johansson, M., Garcia‐Vaz, E., Gomez, M. F., Laakso, M., & Groop, L. (2016) · Kidney International · doi:10.1016/j.kint.2015.12.018 · Cited by 102
Self-citationZheng, M., Wu, C., Yang, K., Yang, Y., Liu, Y., Gao, S., Wang, Q., Li, C., Chen, L., & Li, H. (2021) · Pharmacological Research · doi:10.1016/j.phrs.2020.105367 · Cited by 100
Diabetes pathogenic mechanisms and potential new therapies based upon a novel target called TXNIP
Thielen, L., & Shalev, A. (2018) · Current Opinion in Endocrinology, Diabetes & Obesity · doi:10.1097/med.0000000000000391 · Cited by 99
Meeks, K. A. C., Henneman, P., Venema, A., Addo, J., Bahendeka, S., Burr, T., Danquah, I., Galbete, C., Mannens, M. M. A. M., Mockenhaupt, F. P., et al. (2018) · International Journal of Epidemiology · doi:10.1093/ije/dyy171 · Cited by 117
“TXNIP is involved in insulin resistance; increased expression negatively affects insulin-mediated glucose uptake and correlates with elevated glucose concentrations.(35) This is consistent with the hypomethylation we found in T2D cases and with the link between hypomethylation and increased HbA1c levels.”
ResultEffect of acute physiological hyperinsulinemia on gene expression in human skeletal muscle in vivo
Coletta, D. K., Balas, B., Chavez, A. O., Baig, M., Abdul-Ghani, M., Kashyap, S. R., Folli, F., Tripathy, D., Mandarino, L. J., Cornell, J. E., et al. (2008) · American Journal of Physiology-Endocrinology and Metabolism · doi:10.1152/ajpendo.00607.2007 · Cited by 97
“The uniqueness of the present study compared with previous studies (3, 15, 21, 25, 28, 37, 40, 44) is the inclusion of a control saline infusion group and validation of the results in a separate group of individuals.”
BackgroundResultInfluentialTXNIP/TBP-2: A Master Regulator for Glucose Homeostasis
Yoshihara, E. (2020) · Antioxidants · doi:10.3390/antiox9080765 · Cited by 109
“The stress-induced upregulation of TXNIP is observed in the pancreatic islets during the progression of diabetes in both mice [12] and humans [17].”
BackgroundInfluentialMetabolic profiling in diabetes
Suhre, K. (2014) · Journal of Endocrinology · doi:10.1530/joe-14-0024 · Cited by 93
Tinkov, A. A., Bjørklund, G., Skalny, A. V., Holmgren, A., Геннадиевна, С. М., Chirumbolo, S., & Aaseth, J. (2018) · Cellular and Molecular Life Sciences · doi:10.1007/s00018-018-2745-8 · Cited by 100
“In particular, TXNIP expression was negatively correlated with insulin-stimulated glucose uptake in both humans and 3T3-L1 adipocytes [159].”
Chong, C., Chan, W. P. A., Nguyen, T. H. T., Liu, S., Procter, N. E. K., Ngo, D. T. M., Sverdlov, A. L., Chirkov, Y. Y., & Horowitz, J. D. (2014) · Cardiovascular Drugs and Therapy · doi:10.1007/s10557-014-6538-5 · Cited by 93
“This effect was dependent on intact insulin receptor signaling, rather than simply a reduction in circulating glucose levels: in muscle insulin receptor knockout mice treated with streptozotocin (STZ), insulin failed to suppress TXNIP expression [71].”
BackgroundOka, S.-I., Yoshihara, E., Bizen-Abe, A., Liu, W., Watanabe, M., Yodoi, J., & Masutani, H. (2009) · Endocrinology · doi:10.1210/en.2008-0646 · Cited by 93
“Meanwhile, ithasalso been reported that TBP-2 regulates both insulin-dependent and insulin-independent glucose uptake in human skeletal muscle (29).”
BackgroundAutophagy regulates inflammation following oxidative injury in diabetes
Wang, Y., Li, Y.-B., Yin, J.-J., Wang, Y., Zhu, L.-B., Xie, G.-Y., & Pan, S.-H. (2013) · Autophagy · doi:10.4161/auto.23628 · Cited by 92
“In b cells, TXNIP is downregulated by insulin, and TXNIP expression is consistently higher in humans with T2D.(30)”
BackgroundPeterson, C. W., Stoltzman, C. A., Sighinolfi, M. P., Han, K.-S., & Ayer, D. E. (2010) · Molecular and Cellular Biology · doi:10.1128/mcb.01613-09 · Cited by 89
“However, MondoA(1-400), which contains the MCR region, lacks an identifiable DNA binding domain and cannot activate a TXNIP luciferase reporter (data not shown).”
BackgroundSu, H., Ji, L., Xing, W., Zhang, W., Zhou, H., Qian, X.-H., Wang, X., Gao, F., Sun, X., & Zhang, H. (2013) · Journal of Cellular and Molecular Medicine · doi:10.1111/j.1582-4934.2012.01661.x · Cited by 90
“Hyperglycaemia has been identified as an inducer of Txnip expression in many types of cells including cardiomyocytes [12, 17, 33–35], and Txnip expression is strongly upregulated in human diabetes [36] and diabetic complications [37], indicating that Txnip is a potential diabetogenic signal.”
BackgroundWilliams, K. J., & Wu, X. (2016) · Atherosclerosis · doi:10.1016/j.atherosclerosis.2016.02.004 · Cited by 87
“62 latter effect shows a high degree of tissue selectivity [740, 744].”
BackgroundInfluentialDeng, J., Pan, T., Liu, Z., McCarthy, C., Vicencio, J. M., Cao, L., Alfano, G., Suwaidan, A. A., Yin, M., Beatson, R., et al. (2023) · British Journal of Cancer · doi:10.1038/s41416-023-02442-4 · Cited by 90
“…TXNIP has been reported to regulate the expression of >10 factors that regulate TXNIP ’ s own expression: microRNAs (miRNA-204 and miR-124a) [24 – 26], tumor suppressors (p53 [17, 27] and PTEN [28]), ER components, (protein disul fi de isomerases [29] or apoptosis signal-regulating kinase 1…”
Glutaredoxin-1 Mediates NADPH-Dependent Stimulation of Calcium-Dependent Insulin Secretion
Reinbothe, T. M., Ivarsson, R., Li, D.-Q., Niazi, O., Jing, X., Zhang, E., Stenson, L., Bryborn, U., & Renström, E. (2009) · Molecular Endocrinology · doi:10.1210/me.2008-0306 · Cited by 77
“Worthy of note, the oxidoreductase regulatory protein TXNIP/VDUP-1 is implicated in -cell damage (21, 22), and genetic studies have identified the TXNIP gene to associate with T2DM (23).”
BackgroundTXNIP Links Redox Circuitry to Glucose Control
Muoio, D. M. (2007) · Cell Metabolism · doi:10.1016/j.cmet.2007.05.011 · Cited by 80
Multi-dimensional Transcriptional Remodeling by Physiological Insulin In Vivo
Batista, T. M., Garcia-Martin, R., Cai, W., Konishi, M., O’Neill, B. T., Sakaguchi, M., Kim, J. H., Jung, D. Y., Kim, J. K., & Kahn, C. R. (2019) · Cell Reports · doi:10.1016/j.celrep.2019.02.081 · Cited by 78
“These were also of interest, because Gm11967 and Gm15441 are close to two other insulin-regulated genes, Gck and Txnip genes (Figure S6A), which are well-established regulators of glucose homeostasis in mice and humans (Chutkow et al., 2010; Parikh et al., 2007; Postic et al., 1999; Steele et al., 2014).”
BackgroundDyar, K. A., Ciciliot, S., Tagliazucchi, G. M., Pallafacchina, G., Tothova, J., Argentini, C., Agatea, L., Abraham, R., Ahdesmäki, M., Forcato, M., et al. (2015) · Molecular Metabolism · doi:10.1016/j.molmet.2015.09.004 · Cited by 77
“…box protein O1 ( Foxo1 ), encoding a transcription factor involved in muscle mass regulation, and G(0)/G(1) switch gene 2 ( G0s2) which is induced by insulin in human skeletal muscle [37] and codes for an inhibitor of adipose triglyceride lipase (ATGL) thus blocking lipid droplet degradation [57].”
BackgroundA Txnrd1-dependent metabolic switch alters hepatic lipogenesis, glycogen storage, and detoxification
Iverson, S. V., Eriksson, S. E., Xu, J., Prigge, J. R., Talago, E. A., Meade, T. A., Meade, E. S., Capecchi, M. R., Arnér, E. S. J., & Schmidt, E. E. (2013) · Free Radical Biology and Medicine · doi:10.1016/j.freeradbiomed.2013.05.028 · Cited by 75
“Txnip has been shown to participate in determining the metabolic state of several cell types and systems [7–10], and has been correlated with metabolic switches in others [11, 12].”
BackgroundRabbani, N., Xue, M., Weickert, M. O., & Thornalley, P. J. (2021) · Nutrients · doi:10.3390/nu13072374 · Cited by 74
Unraveling the role of thiosulfate sulfurtransferase in metabolic diseases
Kruithof, P. D., Lunev, S., Lozano, S. P. A., Batista, F. D. A., Al-Dahmani, Z. M., Joles, J. A., Dolga, A. M., Groves, M. R., & van Goor, H. (2020) · Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease · doi:10.1016/j.bbadis.2020.165716 · Cited by 81
Buaban, S., Lengnudum, K., Boonkum, W., & Phakdeedindan, P. (2021) · Journal of Dairy Science · doi:10.3168/jds.2020-19826 · Cited by 79
Ao, H., Li, H., Zhao, X., Liu, B., & Lu, L. (2021) · Life Sciences · doi:10.1016/j.lfs.2020.118988 · Cited by 72
Domingues, A., Jolibois, J., Marquet, P., & Nivet‐Antoine, V. (2021) · International Journal of Molecular Sciences · doi:10.3390/ijms22041693 · Cited by 69
“Insulin and cellular glucose influx reciprocally regulate TXNIP expression in humans: glucose influx positively regulates TXNIP expression and its suppression by insulin [115,153].”
BackgroundThioredoxin-interacting Protein (Txnip) Gene Expression
Yu, F., Chai, T. F., He, H., Hagen, T., & Luo, Y. (2010) · Journal of Biological Chemistry · doi:10.1074/jbc.m110.108290 · Cited by 72
Kim, H. K., Chen, W., & Andreazza, A. C. (2015) · Neural Plasticity · doi:10.1155/2015/408136 · Cited by 81
“Oxidative damage to lipids, DNA, and proteins in patients with BD is some of the most consistently reported alterations in BD, which is in agreement with these findings [2, 3, 19].”
ResultMondoA Senses Non-glucose Sugars
Stoltzman, C. A., Kaadige, M. R., Peterson, C. W., & Ayer, D. E. (2011) · Journal of Biological Chemistry · doi:10.1074/jbc.m111.275503 · Cited by 70
Physiological Insights Gained from Gene Expression Analysis in Obesity and Diabetes
Keller, M. P., & Attie, A. D. (2010) · Annual Review of Nutrition · doi:10.1146/annurev.nutr.012809.104747 · Cited by 69
“(110) identified Txnip as a regulator of glucose metabolism in humans, initially through a microarray survey.”
A coding and non-coding transcriptomic perspective on the genomics of human metabolic disease
Timmons, J. A., Atherton, P. J., Larsson, O. S., Sood, S., Blokhin, I. O., Brogan, R. J., Volmar, C., Josse, A. R., Slentz, C. A., Wahlestedt, C., et al. (2018) · Nucleic Acids Research · doi:10.1093/nar/gky570 · Cited by 80
Bioenergetic dysfunction in the pathogenesis of intervertebral disc degeneration
Song, C., Hu, P., Peng, R., Li, F., Fang, Z., & Xu, Y. (2024) · Pharmacological Research · doi:10.1016/j.phrs.2024.107119 · Cited by 73
Shaked, M., Ketzinel‐Gilad, M., Cerasi, E., Kaiser, N., & Leibowitz, G. (2011) · PLoS ONE · doi:10.1371/journal.pone.0028804 · Cited by 77
“TXNIP inhibits glucose uptake in different tissues [40,41], thus suppression of TXNIP by FFA may promote glucose uptake, thereby ensuring adequate glycolytic intermediates for effective fatty acid metabolism.”
MondoA coordinately regulates skeletal myocyte lipid homeostasis and insulin signaling
Ahn, B., Soundarapandian, M. M., Sessions, H., Peddibhotla, S., Roth, G. P., Li, J.-L., Sugarman, E., Koo, A., Malany, S., Wang, M., et al. (2016) · Journal of Clinical Investigation · doi:10.1172/jci87382 · Cited by 70
“Interestingly, TXNIP expression is increased in skeletal muscle of type 2 diabetes patients and inversely correlated with insulin-stimulated glucose uptake (20).”
BackgroundThioredoxin binding protein (TBP)-2/Txnip and α-arrestin proteins in cancer and diabetes mellitus
Masutani, H., Yoshihara, E., Masaki, S., Chen, Z., & Yodoi, J. (2011) · Journal of Clinical Biochemistry and Nutrition · doi:10.3164/jcbn.11-36sr · Cited by 72
Elgort, M., O'Shea, J. M., Jiang, Y., & Ayer, D. E. (2010) · Genes & Cancer · doi:10.1177/1947601910389604 · Cited by 75
Liao, W., Xu, N., Zhang, H., Liao, W., Wang, Y., Wang, S., Zhang, S., Jiang, Y., Xie, W., & Zhang, Y. (2022) · Clinical and Translational Medicine · doi:10.1002/ctm2.699 · Cited by 74
A Critical Role for Thioredoxin-Interacting Protein in Diabetes-Related Impairment of Angiogenesis
Dunn, L., Simpson, P. J. L., Prosser, H. C. G., Lecce, L., Yuen, G., Buckle, A., Sieveking, D. P., Vanags, L. Z., Lim, P., Chow, R., et al. (2013) · Diabetes · doi:10.2337/db13-0417 · Cited by 70
“TXNIP is an exquisitely glucoseinducible gene as a result of a carbohydrate response element in the promoter (7) and it is overexpressed in both diabetic animals and humans (8,9).”
BackgroundThe glucose-sensing transcription factor MLX promotes myogenesis via myokine signaling
Hunt, L. C., Xu, B., Finkelstein, D., Fan, Y., Carroll, P. A., Cheng, P.-F., Eisenman, R. N., & Demontis, F. (2015) · Genes & Development · doi:10.1101/gad.267419.115 · Cited by 64
“2009) and proteins that regulate glucose uptake, including thioredoxin-interacting protein (TXNIP) (Parikh et al. 2007; Wu et al. 2013).”
Li‐Weber, M. (2014) · International Journal of Cancer · doi:10.1002/ijc.29013 · Cited by 72
“TXNIP is a strong regulator of cellular energy status and has been shown to be a powerful negative regulator of glucose uptake.(50,51) Increase of TXNIP expression blocks glucose uptake and, consequently, impairs proliferation of malignant and premalignant cells in vitro and in vivo in mouse tumor models.”
BackgroundShao, W., Yu, Z., Fantus, I. G., & Jin, T. (2010) · Cellular Signalling · doi:10.1016/j.cellsig.2010.04.001 · Cited by 75
Safety and anti-hyperglycemic efficacy of various tea types in mice
Han, M., Zhao, G., Wang, Y., Wang, D., Sun, F., Ning, J., Wan, X., & Zhang, J. (2016) · Scientific Reports · doi:10.1038/srep31703 · Cited by 63
Xiao, Y., Huang, Y. Y., Wang, H., Wu, Y., Leng, Y., Liu, M., Sun, Q., & Xia, Z. (2016) · Oxidative Medicine and Cellular Longevity · doi:10.1155/2016/2386068 · Cited by 65
“TXNIP expression is markedly upregulated in human diabetes and diabetic complications [49, 50], indicating that TXNIP is a potential therapeutic target of diabetes.”
BackgroundEffect of betaine on hepatic insulin resistance through FOXO1-induced NLRP3 inflammasome
Kim, D. H., Kim, S. M., Lee, B., Lee, E. K., Chung, K. W., Moon, K. M., An, H. J., Kim, K. M., Yu, B. P., & Chung, H. Y. (2017) · The Journal of Nutritional Biochemistry · doi:10.1016/j.jnutbio.2017.04.014 · Cited by 67
Identification of thioredoxin-interacting protein (TXNIP) as a downstream target for IGF1 action
Nagaraj, K., Lapkina-Gendler, L., Sarfstein, R., Gurwitz, D., Pasmanik‐Chor, M., Laron, Z., Yakar, S., & Werner, H. (2018) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1715930115 · Cited by 64
“Of interest, TXNIP has been identified as one of the most potently suppressed skeletal muscle mRNAs in healthy individuals subjected to a hyperinsulinemic-euglycemic clamp (44).”
BackgroundXu, L., Lin, X., Guan, M., Zeng, Y., & Liu, Y. (2019) · Oxidative Medicine and Cellular Longevity · doi:10.1155/2019/1896041 · Cited by 68
“We know that the expression of TXNIP, an endogenous inhibitor of TRX, is regulated by glucose [40] and free fatty acid [41].”
BackgroundDeBalsi, K. L., Wong, K. E., Koves, T. R., Slentz, D. H., Seiler, S. E., Wittmann, A. H., Ilkayeva, O. R., Stevens, R. D., Perry, C. G. R., Lark, D. S., et al. (2014) · Journal of Biological Chemistry · doi:10.1074/jbc.m113.511535 · Cited by 60
“Prominent among these is insulin, as TXNIP was identified as one of the most potently suppressed skeletal muscle mRNAs in healthy human individuals subjected to a hyperinsulinemic-euglycemic clamp (14).”
BackgroundEvaluation of mulberry leaves’ hypoglycemic properties and hypoglycemic mechanisms
Chen, S., Xi, M., Gao, F., Li, M., Dong, T., Geng, Z., Liu, C., Huang, F., Wang, J., Li, X., et al. (2023) · Frontiers in Pharmacology · doi:10.3389/fphar.2023.1045309 · Cited by 70
Huy, H., Song, H. Y., Kim, M. J., Kim, W. S., Kim, D. O., Byun, J., Lee, J., Park, Y., Kim, T., Yoon, S. R., et al. (2018) · Aging Cell · doi:10.1111/acel.12836 · Cited by 57
Jorquera, G., Russell‐Guzmán, J., Monsalves‐Álvarez, M., Cruz, G., Valladares-Ide, D., Basualto-Alarcón, C., Barrientos, G. C., Estrada, M., & Llanos, P. (2021) · International Journal of Molecular Sciences · doi:10.3390/ijms22063254 · Cited by 68
“Interestingly, the expression of TXNIP in skeletal muscle is modulated by insulin, with a decrease in TXNIP mRNA levels observed in response to a euglycemic–hyperinsulinemic clamp [72].”
BackgroundByon, C. H., Han, T.-Y., Wu, J., & Hui, S. T. Y. (2015) · Atherosclerosis · doi:10.1016/j.atherosclerosis.2015.05.020 · Cited by 62
“Txnip is a key regulator of glucose utilization and fuel metabolism in skeletal muscle [19,34,35] and has recently emerged as a crucial mediator of inflammation [18].”
Lappalainen, Z., Lappalainen, J., Oksala, N., Laaksonen, D. E., Khanna, S., Sen, C. K., & Atalay, M. (2008) · Journal of Applied Physiology · doi:10.1152/japplphysiol.91252.2008 · Cited by 66
“An increased TXNip expression has been described in response to high glucose concentrations in human pancreatic islets (56), aortic smooth muscle cells (53), kidney mesangial cells (31), adipocytes and skeletal muscle cells (45), and also in vivo in streptozotocininduced diabetic mice kidneys (31) and in the skeletal…”
Chronic acidosis rewires cancer cell metabolism through PPARα signaling
Rolver, M. G., Holland, L. K. K., Ponniah, M., Prasad, N. S., Yao, J., Schnipper, J., Kramer, S. H., Elingaard-Larsen, L. O., Pedraz‐Cuesta, E., Liu, B., et al. (2022) · International Journal of Cancer · doi:10.1002/ijc.34404 · Cited by 61
“Given the known inhibition of glucose uptake by TXNIP, 51 we suggest that TXNIP upregulation contributes to the PPAR α - induced metabolic shift by limiting glucose uptake.”
BackgroundDiabetes regulates fructose absorption through thioredoxin-interacting protein
Dotimas, J. R., Lee, A. W., Schmider, A. B., Carroll, S. H., Shah, A., Bilen, J., Elliott, K. R., Myers, R. B., Soberman, R. J., Yoshioka, J., et al. (2016) · eLife · doi:10.7554/elife.18313 · Cited by 49
“While elevated glucose levels promote Txnip expression, elevated insulin levels decrease Txnip expression (Parikh et al., 2007).”
BackgroundResultInfluentialSelf-citationSelenoprotein M Promotes Hypothalamic Leptin Signaling and Thioredoxin Antioxidant Activity
Gong, T., Hashimoto, A. C., Sasuclark, A. R., Khadka, V. S., Gurary, A., & Pitts, M. W. (2019) · Antioxidants and Redox Signaling · doi:10.1089/ars.2018.7594 · Cited by 65
“Cruz), mouse anti-TXN 2 (Cat # sc-13320, 1:500; Santa Cruz), rabbit anti-TXNRDs 1 (Cat # NBP1-96738, 1:1000; Novus Biologicals, Littleton, CO), mouse anti-TXNRDs 2 (Cat # 365714, 1:500; Santa Cruz), mouse anti-TXNIP (Cat # sc-13320, 1: 500; Santa Cruz), and mouse anti-b -Actin (Cat # 3700, 1:5000; Cell Signaling).”
InfluentialNOD-like Receptors in the Eye: Uncovering Its Role in Diabetic Retinopathy
Lim, R. R., Wieser, M. E., Ganga, R., Barathi, V. A., Lakshminarayanan, R., Mohan, R. R., Hainsworth, D. P., & Chaurasia, S. S. (2020) · International Journal of Molecular Sciences · doi:10.3390/ijms21030899 · Cited by 61
Thiol Redox Transitions by Thioredoxin and Thioredoxin-Binding Protein-2 in Cell Signaling
Yoshihara, E., Chen, Z., Matsuo, Y., Masutani, H., & Yodoi, J. (2010) · Methods in enzymology on CD-ROM/Methods in enzymology · doi:10.1016/s0076-6879(10)74005-2 · Cited by 63
“Furthermore, a recent reports have shown that TBP-2 regulates glucose uptake in human skeletal muscle (Parikh et al., 2007), hepatic glucose production (Chutkow et al.”
BackgroundRabbani, N., Xue, M., & Thornalley, P. J. (2022) · International Journal of Molecular Sciences · doi:10.3390/ijms23042165 · Cited by 67
Ferreira, N. E., Omae, S. V., Pereira, A., Rodrigues, M. V., Miyakawa, A. A., Campos, L. C. G., Santos, P. C. J. L., Dallan, L. A., Martinez, T. L. D. R., Santos, R. D., et al. (2011) · Atherosclerosis · doi:10.1016/j.atherosclerosis.2011.12.009 · Cited by 61
Novel approaches to restore beta cell function in prediabetes and type 2 diabetes
Salunkhe, V. A., Veluthakal, R., Kahn, S. E., & Thurmond, D. C. (2018) · Diabetologia · doi:10.1007/s00125-018-4658-3 · Cited by 65
“For instance, thioredoxin interacting protein (TXNIP) expression is elevated in type 2 diabetic human skeletal muscle, and its silencing confers improved peripheral tissue glucose uptake [24]; TXNIP inhibition also indirectly promotes beta cell function [25].”
Thioredoxin Regulates Adipogenesis through Thioredoxin-interacting Protein (Txnip) Protein Stability
Chutkow, W. A., & Lee, R. T. (2011) · Journal of Biological Chemistry · doi:10.1074/jbc.m111.267666 · Cited by 65
Self-citationThe Emerging Role of Thioredoxin-Interacting Protein in Myocardial Ischemia/Reperfusion Injury
Wang, B. F., & Yoshioka, J. (2016) · Journal of Cardiovascular Pharmacology and Therapeutics · doi:10.1177/1074248416675731 · Cited by 57
“These agents include calcium channel blockers,(95,96) angiotensin-converting enzyme inhibitors,(6,97) angiotensin-II receptor blockers,(98) glucagon-like peptide-1 agonists,(99) and insulin.(20) To date, however, there is no pharmacological therapy specifically designed to inhibit Txnip expression.”
BackgroundArrestin domain-containing 3 (Arrdc3) modulates insulin action and glucose metabolism in liver
Batista, T. M., Dağdeviren, S., Carroll, S. H., Cai, W., Melnik, V. Y., Noh, H. L., Saengnipanthkul, S., Kim, J. K., Kahn, C. R., & Lee, R. T. (2020) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1922370117 · Cited by 53
“The best-characterized member of the α-arrestins, Txnip, has been implicated in regulation of insulin sensitivity and adipogenesis in mice and humans (23, 24).”
BackgroundSelf-citationShaked, M., Ketzinel‐Gilad, M., Ariav, Y., Cerasi, E., Kaiser, Ν., & Leibowitz, G. (2009) · Diabetologia · doi:10.1007/s00125-009-1274-2 · Cited by 67
“Moreover, treatment of muscle insulin receptor knockout mice with insulin, while normalising blood glucose, failed to decrease TXNIP production in muscle [15, 22], indicating that the suppression of TXNIP by insulin in vivo requires intact insulin signalling and is not simply secondary to decreased blood glucose.”
BackgroundInfluentialLee, S., Kim, S. M., Dotimas, J., Li, L., Feener, E. P., Baldus, S. E., Myers, R. B., Chutkow, W. A., Patwari, P., Yoshioka, J., et al. (2014) · EMBO Molecular Medicine · doi:10.15252/emmm.201302561 · Cited by 56
“Since Txnip is one of the most strongly upregulated genes in diabetes (Parikh et al , 2007), this reveals Txnip as a key negative feedback regulatory mechanism of the UPR to decrease Xbp1s levels via direct regulation of PDI.”
Self-citationGokulakrishnan, K., Mohanavalli, K. T., Monickaraj, F., Mohan, V., & Balasubramanyam, M. (2009) · Molecular and Cellular Biochemistry · doi:10.1007/s11010-008-9996-x · Cited by 52
“In addition, a recent human study [39] demonstrated that TXNIP modifies glucose uptake in adipocytes and skeletal muscle, and TXNIP expression was elevated even in the muscle of prediabetics.”
BackgroundMultilevel regulation of an α-arrestin by glucose depletion controls hexose transporter endocytosis
Hovsepian, J., Defenouillère, Q., Albanèse, V., Váchová, L., Garcia, C., Palková, Z., & Sébastien Léon, A. (2017) · The Journal of Cell Biology · doi:10.1083/jcb.201610094 · Cited by 56
“TXN IP is an important metabolic regulator, particularly of glucose and lipid metabolism (Parikh et al., 2007; Patwari and Lee, 2012; Shen et al., 2015; Doti-mas et al., 2016).”
New Insight Into Metformin Action: Regulation of ChREBP and FOXO1 Activities in Endothelial Cells
Li, X., Kover, K. L., Heruth, D. P., Watkins, D. J., Moore, W. V., Jackson, K., Zang, M., Clements, M. A., & Yan, Y. (2015) · Molecular Endocrinology · doi:10.1210/me.2015-1090 · Cited by 52
Perrone, L., Sbai, O., Nawroth, P. P., & Bierhaus, A. (2012) · International Journal of Alzheimer's Disease · doi:10.1155/2012/734956 · Cited by 51
“However, recent studies demonstrated that TXNIP regulates glucose metabolism [88, 89], and its expression is associated to the senescence process [90].”
BackgroundNasoohi, S., Parveen, K., & Ishrat, T. (2018) · Journal of Alzheimer’s Disease · doi:10.3233/jad-180735 · Cited by 50
“TXNIPasaregulatorofcellular oxidativestatusinresponsetonutrients,isamajor effectorofhyperglycemiatocauseinsulinresistance [64],andisoverexpressedinstantlyinresponseto hyperglycemia[65].”
Redox-dependent and independent effects of thioredoxin interacting protein
Cao, X., He, W., Pang, Y., Cao, Y., & Qin, A. (2020) · Biological Chemistry · doi:10.1515/hsz-2020-0181 · Cited by 54
Chai, T. F., Hong, S. Y., He, H., Zheng, L., Hagen, T., Luo, Y., & Yu, F. (2012) · Cellular Signalling · doi:10.1016/j.cellsig.2012.04.017 · Cited by 50
Kovalik, J.-P., Slentz, D., Stevens, R. D., Kraus, W. E., Houmard, J. A., Nicoll, J. B., Lea-Currie, Y. R., Everingham, K., Kien, C. L., Buehrer, B. M., et al. (2011) · Diabetes · doi:10.2337/db10-0427 · Cited by 46
Du, C., Wu, M. T., Liu, H., Ren, Y., Du, Y., Wu, H., Wei, J., Liu, C., Yao, F., Wang, H., et al. (2016) · The International Journal of Biochemistry & Cell Biology · doi:10.1016/j.biocel.2016.08.006 · Cited by 51
Wang, S., Sheng, H., Bai, Y., Weng, Y., Fan, X., Zheng, F., Fu, J., & Zhang, F. (2020) · Phytomedicine · doi:10.1016/j.phymed.2020.153454 · Cited by 50
Masson, E., Koren, S., Razik, F., Goldberg, H. J., Kwan, E. P., Sheu, L., Gaisano, H. Y., & Fantus, I. G. (2009) · American Journal of Physiology-Endocrinology and Metabolism · doi:10.1152/ajpendo.90619.2008 · Cited by 50
TXNIP in Agrp Neurons Regulates Adiposity, Energy Expenditure, and Central Leptin Sensitivity
Blouet, C., Liu, S., Jo, Y., Chua, S. C., & Schwartz, G. J. (2012) · Journal of Neuroscience · doi:10.1523/jneurosci.0353-12.2012 · Cited by 52
“…through pleiotropic actions that include regulation of -cell function, hepatic glucose production, peripheral glucose uptake, adipogenesis, and substrate utilization (Bodnar et al., 2002; Hui et al., 2004, 2008; Sheth et al., 2005; Parikh et al., 2007; Chutkow et al., 2008; Shalev, 2008).”
Specific NLRP3 inflammasome inhibitors: promising therapeutic agents for inflammatory diseases
Vong, C. T., Tseng, H. H. L., Yao, P., Yu, H., Wang, S., Zhong, Z., & Wang, Y. (2021) · Drug Discovery Today · doi:10.1016/j.drudis.2021.02.018 · Cited by 51
Borowiec, A. M., Właszczuk, A., Olakowska, E., & Lewin‐Kowalik, J. (2022) · Medicine and Pharmacy Reports · doi:10.15386/mpr-2187 · Cited by 49
“It was observed that reduction of TXNIP expression by siRNA gene silencing enhanced both basal and insulinstimulated glucose uptake [15].”
BackgroundInfluentialMatrone, C., Djelloul, M., Taglialatela, G., & Perrone, L. (2015) · PubMed · doi:10.14670/hh-30.125 · Cited by 44
Glucose regulation of β ‐cell stress in type 2 diabetes
Leibowitz, G., Bachar-Wikström, E., Shaked, M., Sinai, A., Ketzinel‐Gilad, M., Cerasi, E., & Kaiser, Ν. (2010) · Diabetes Obesity and Metabolism · doi:10.1111/j.1463-1326.2010.01280.x · Cited by 51
“Indeed, TXNIP regulates hepatic glucose production [61], cardiac muscle glucose utilization [62] and peripheral insulin resistance in humans [63].”
BackgroundThe α‐arrestin family of ubiquitin ligase adaptors links metabolism with selective endocytosis
Kahlhofer, J., Léon, S., Teis, D., & Schmidt, O. (2020) · Biology of the Cell · doi:10.1111/boc.202000137 · Cited by 47
“Furthermore, TXNIP deletion enhances glucose uptake in skeletal muscle and adipose tissue [Parikh et al., 2007; Waldhart et al., 2017].”
BackgroundThioredoxin-Interacting Protein in Cancer and Diabetes
Masutani, H. (2021) · Antioxidants and Redox Signaling · doi:10.1089/ars.2021.0038 · Cited by 53
“Knockdown of Txnip expression was found to enhance glucose uptake in cultured adipocytes and primary human skeletal muscle myocytes, whereas Txnip overexpression inhibited glucose uptake (118).”
BackgroundAn extended Myc network contributes to glucose homeostasis in cancer and diabetes
Christopher, W. P. (2011) · Frontiers in bioscience · doi:10.2741/3848 · Cited by 53
O'Shea, J. M., & Ayer, D. E. (2013) · Cold Spring Harbor Perspectives in Medicine · doi:10.1101/cshperspect.a014258 · Cited by 47
“This may reflect TXNIP’s proapoptotic activity, its stabilization of the cell-cycle inhibitor p27Kip1 (CDK1B), its destabilization of hypoxia inducible factor 1a (HIF-1a), or its negative regulation of glucose utilization (Jeon et al. 2005; Muoio 2007; Parikh et al. 2007; Shin et al. 2008; Stoltzman et al. 2008, 2011).”
BackgroundCerk, I. K., Salzburger, B., Boeszoermenyi, A., Heier, C., Pillip, C., Romauch, M., Schweiger, M., Cornaciu, I., Lass, A., Zimmermann, R., et al. (2014) · Journal of Biological Chemistry · doi:10.1074/jbc.m114.602599 · Cited by 45
“mRNA levels of G0S2 respond strongly to hormonal stimuli, yet the dose-dependent inhibition of ATGL by G0S2 itself is reported to be independent of phosphorylation events (18, 20, 21, 28, 29).”
BackgroundYu, W., Chen, C., Zhuang, W., Wang, W., Liu, W., Zhao, H., Lv, J., Xie, D., Wang, Q., He, F., et al. (2021) · Free Radical Biology and Medicine · doi:10.1016/j.freeradbiomed.2021.11.034 · Cited by 49
Emerging Glycation-Based Therapeutics—Glyoxalase 1 Inducers and Glyoxalase 1 Inhibitors
Rabbani, N., & Thornalley, P. J. (2022) · International Journal of Molecular Sciences · doi:10.3390/ijms23052453 · Cited by 49
α-Arrestins and Their Functions: From Yeast to Human Health
Zbieralski, K., & Wawrzycka, D. (2022) · International Journal of Molecular Sciences · doi:10.3390/ijms23094988 · Cited by 47
“The most prominent example is TXNIP, the expression of which is induced in fasting mice [126] and is also downregulated in response to insulin and upregulated by glucose [154].”
BackgroundTranscriptional signatures throughout development: the effects of mouse embryo manipulation in vitro
Feuer, S. K., Liu, X., Donjacour, A., Simbulan, R., Maltepe, E., & Rinaudo, P. (2017) · Reproduction · doi:10.1530/rep-16-0473 · Cited by 42
Yu, F., & Luo, Y. (2009) · PLoS ONE · doi:10.1371/journal.pone.0008397 · Cited by 43
“Most interestingly, the expression level of Txnip is tightly correlated with the extracellular glucose levels [22,25,27,28,37], and this glucose-induced Txnip expression negatively feeds back to the cellular glucose uptake system [17,20].”
BackgroundLlopis-Torregrosa, V., Ferri-Blázquez, A., Adam‐Artigues, A., Deffontaines, E., van Heusden, G. P. H., & Yenush, L. (2016) · Journal of Biological Chemistry · doi:10.1074/jbc.m116.733923 · Cited by 43
“Knockdown experiments reducing Txnip expression show a marked increase in glucose uptake in an insulin-responsive cell model (31), consistent with the results presented here for the homologous yeast system.”
ResultInflammatory and Oxidative Stress Markers in Skeletal Muscle of Obese Subjects
Catalán, V., Frühbeck, G., & Gómez‐Ambrosi, J. (2018) · Elsevier eBooks · doi:10.1016/b978-0-12-812504-5.00008-8 · Cited by 66
Warburg effect regulated by amphiregulin in the development of colorectal cancer
Nam, S. O., Yotsumoto, F., Miyata, K., Fukagawa, S., Yamada, H., Kuroki, M., & Miyamoto, S. (2015) · Cancer Medicine · doi:10.1002/cam4.416 · Cited by 41
“MondoA-MLX also binds to ChoREs in the promoter of the thioredoxin-interacting protein (Txnip) and induces the expression of Txnip, which is an important regulator of glucose metabolism that functions by inhibiting cellular uptake of glucose [28, 29].”
BackgroundAdenosine-Containing Molecules Amplify Glucose Signaling and Enhance Txnip Expression
Yu, F., Goh, S. R., Dai, R.-P., & Luo, Y. (2009) · Molecular Endocrinology · doi:10.1210/me.2008-0383 · Cited by 47
“glucose uptake in peripheral tissues (14).”
BackgroundInfluentialLee, H.-K., Lee, S.-Y., Bae, H., Kang, H., & Kim, S. J. (2016) · Scientific Reports · doi:10.1038/srep25287 · Cited by 49
“TXNIP is a potent negative regulator of glucose uptake, aerobic glycolysis, and glycolytic gene expression; thus, its repression is associated with active tumor growth 35,36 .”
The Function of Thioredoxin‐Binding Protein‐2 (TBP‐2) in Different Diseases
Hu, J., & Yu, Y. (2018) · Oxidative Medicine and Cellular Longevity · doi:10.1155/2018/4582130 · Cited by 44
“Many studies have found that TBP-2 is overexpressed in patients with T2DM (type II diabetes mellitus) [1], cardiovascular diseases [2], and cataracts [3] and many studies have also shown that TBP-2 expression is decreased in tumor cells [4], such as those caused by colorectal and gastric cancers [5].”
BackgroundInfluential
Metadata
- Authors
- Parikh, H., Carlsson, E., Chutkow, W. A., Johansson, L. E., Storgaard, H., Poulsen, P., Saxena, R., Ladd, C., Schulze, P. C., Mazzini, M. J., Jensen, C. B., Krook, A., Björnholm, M., Tornqvist, H., Zierath, J. R., Ridderstråle, M., Altshuler, D., Lee, R. T., Vaag, A., Groop, L. C., & Mootha, V. K.
- Affiliations
- Lund University (SE)
- Brigham and Women's Hospital (US)
- Broad Institute (US)
- Karolinska Institutet (SE)
- Novo Nordisk (Denmark) (DK)
- University of Helsinki (FI)
- Corresponding author
- Groop, Leif C
- Mootha, Vamsi K
- ORCID
- Venue
- PLoS Medicine
- Publisher
- Public Library of Science (PLoS)
- Published
- 2007-05-01
- Volume
- 4
- Issue
- 5
- Pages
- e158
- ISSN
- 1549-1277 (ISSN-L)
- 1549-1676
- PMC
- PMC1858708
- OpenAlex
- W2158951820
- Cited by
- 495
- References
- 57
- Citations by year
- 2026: 10 · 2025: 17 · 2024: 24 · 2023: 41 · 2022: 35 · 2021: 39 · 2020: 34 · 2019: 22 · 2018: 29 · 2017: 21 · 2016: 29 · 2015: 29 · 2014: 23 · 2013: 28 · 2012: 31
- FWCI
- 8.34
- Type
- journal article
- Language
- en
- Open access
- gold
- doi.org
- Locations
- PLoS Medicine (publishedVersion, cc-by)
- PubMed Central (publishedVersion, cc-by)
- PubMed (publishedVersion)
- Digital Access to Scholarship at Harvard (DASH) (Harvard University) (submittedVersion, cc-by)
- DOAJ (DOAJ: Directory of Open Access Journals) (submittedVersion, cc-by-sa)
- Figshare (submittedVersion, cc-by)
- Lund University Publications (Lund University) (submittedVersion)
- Funders
- American Diabetes Association
- Burroughs Wellcome Fund
- Richard and Susan Smith Family Foundation
- European Commission
- Karolinska Institutet
- Novo Nordisk
- Vetenskapsrådet
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Metabolism, Diabetes, and Cancer
- Health Sciences › Medicine › Physiology (medical) › Adipose Tissue and Metabolism
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Adipokines, Inflammation, and Metabolic Diseases
- Keywords
- TXNIP, type 2 diabetes, skeletal muscle glucose uptake, peripheral glucose metabolism, insulin signaling, adipocytes, prediabetes, glucose homeostasis, insulin-independent glucose uptake, genetic association
- MeSH terms
- Animals, Blood Glucose, Carrier Proteins, Cells, Cultured, Diabetes Mellitus, Type 2, DNA-Binding Proteins, Gene Expression Regulation, Homeostasis, Humans, Hypoglycemic Agents, Insulin, Promoter Regions, Genetic, Glucose Clamp Technique, Linkage Disequilibrium, Polymerase Chain Reaction, Adipocytes, Glucose Intolerance, Muscle, Skeletal, Genetic Predisposition to Disease, Polymorphism, Single Nucleotide, Protein Array Analysis, Qb-SNARE Proteins, Proto-Oncogene Proteins c-bcl-6
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.